Introduction:
The Pharmacovigilance Certification Exam is designed to evaluate knowledge and competency in the monitoring, detection, assessment, and reporting of adverse drug reactions (ADRs) and drug safety issues. Pharmacovigilance plays a vital role in ensuring that medicines used in clinical practice remain safe and effective throughout their lifecycle. This certification assessment focuses on the principles of drug safety monitoring, ADR identification, reporting systems, and regulatory requirements that support patient safety. The exam helps learners and professionals demonstrate their understanding of pharmacovigilance practices and their role in maintaining safe medication use in healthcare systems.

Scope:
The scope of the Pharmacovigilance Certification Exam includes the assessment of key concepts related to adverse drug reaction reporting, drug safety monitoring, and pharmacovigilance systems. It covers topics such as identification and classification of ADRs, reporting procedures, signal detection, risk management strategies, and regulatory frameworks that govern drug safety surveillance. The assessment also addresses the responsibilities of healthcare professionals in detecting, documenting, and communicating drug safety information to support public health.

Objectives:

• To assess knowledge of pharmacovigilance principles and drug safety monitoring systems.
• To evaluate understanding of adverse drug reaction identification and reporting procedures.
• To strengthen awareness of regulatory guidelines and safety surveillance practices.
• To reinforce the role of healthcare professionals in maintaining medication safety.
• To support professional competence in pharmacovigilance and drug safety management.

Who Can Enroll:

• Pharmacy students (D.Pharm, B.Pharm, M.Pharm, Pharm.D).
• Professionals working in pharmacovigilance, clinical research, or regulatory affairs.
• Pharmacy graduates preparing for careers in drug safety, pharmaceutical industry, or healthcare monitoring systems.
• Healthcare professionals interested in enhancing their knowledge of ADR reporting and pharmacovigilance practices.